國家衛生研究院 NHRI:Item 3990099045/12417

NHRI > National Institute of Cancer Research > Jacqueline Whang-Peng(1996-2007) > Periodical Articles > Item 3990099045/12417

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/12417

Title:	Hematuria induced by combination regorafenib and hyperthermia - a radiation recall effect
Authors:	Zheng, YM;Chow, JM;Chang, CL;Chao, LH;Whang-Peng, J;Lai, GM
Contributors:	National Institute of Cancer Research
Abstract:	Introduction: Radiation recall, which was first described in 1959, remains a rare and erratic inflammatory phenomenon that manifests in previously irradiated areas after the subsequent administration of chemotherapeutic agents [1]. Anthracyclines, taxanes, antimetabolites, and topoisomerase inhibitors have all been associated with radiation recall [2], as have specific agents such as dabrafenib, pazopanib, sorafenib, and trastuzumab [3–5]. The interval between the cessation of radiation and manifestation of the inflammation can range from a few days to 15 years [6].
Date:	2019-12
Relation:	International Journal of Hyperthermia. 2019 Dec;36(1):1185-1188.
Link to:	http://dx.doi.org/10.1080/02656736.2019.1687941
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0265-6736&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000505265300023
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85076321515
Appears in Collections:	[Jacqueline Whang-Peng(1996-2007)] Periodical Articles [Gi-Ming Lai(2004-2008)] Periodical Articles

Files in This Item:

File	Description	Size	Format
PUB31805792.pdf		902Kb	Adobe PDF	274	View/Open